Early conversion to a CNI-free immunosuppression with SRL after renal transplantation-Long-term follow-up of a multicenter trial.-论文-万方医学网

第一作者： Joachim,Andrassy

第一单位： Department of General, Visceral, and Transplant Surgery, Ludwig-Maximilian's University, Campus Grosshadern, Munich, Germany.

作者： Joachim,Andrassy ^[1] ; Markus,Guba ^[1] ; Antje,Habicht ^[2] ; Michael,Fischereder ^[3] ; Johann,Pratschke ^[4] ; Andreas,Pascher ^[5] ; Katharina M,Heller ^[6] ; Bernhard,Banas ^[7] ; Oliver,Hakenberg ^[8] ; Thomas,Vogel ^[9] ; Bruno,Meiser ^[2] ; Andrea,Dick ^[10] ; Jens,Werner ^[1] ; Teresa,Kauke ^[11] ; SMART-Study Group

作者单位： Department of General, Visceral, and Transplant Surgery, Ludwig-Maximilian's University, Campus Grosshadern, Munich, Germany. ^[1] Transplant Department, Ludwig-Maximilian's University, Campus Grosshadern, Munich, Germany. ^[2] Department of Medicine, MED IV, Nephrology, Ludwig-Maximilian's University, Campus Grosshadern, Munich, Germany. ^[3] Department of General, Visceral, and Transplant Surgery, Charité, Campus Virchow-Clinic, Berlin, Germany. ^[4] Department of General, Visceral, and Transplant Surgery, Charité, Campus Virchow-Clinic, Berlin, Germany.;Department of General, Visceral, and Transplant Surgery, University of Münster, Münster, Germany. ^[5] Department of Medicine, Division of Nephrology, University of Erlangen, Germany. ^[6] Department of Internal Medicine II, Nephrology and Transplantation, University Medical Center, Regensburg, Germany. ^[7] Department of Urology, University of Rostock, Germany. ^[8] Department of General, Visceral, and Transplant Surgery, University of Münster, Münster, Germany. ^[9] Laboratory for Immunogenetics, Division of Transfusion Medicine, Cell Therapeutics and Hemostaseology, Ludwig-Maximilian's University, Munich, Germany. ^[10] Department of General, Visceral, and Transplant Surgery, Ludwig-Maximilian's University, Campus Grosshadern, Munich, Germany.;Laboratory for Immunogenetics, Division of Transfusion Medicine, Cell Therapeutics and Hemostaseology, Ludwig-Maximilian's University, Munich, Germany. ^[11]

医学主题词成年人(Adult);抗体特异性(Antibody Specificity);用药计划表(Drug Administration Schedule);女(雌)性(Female);随访研究(Follow-Up Studies);肾小球滤过率(Glomerular Filtration Rate);移植物排斥(Graft Rejection);移植物存活(Graft Survival);人类(Humans);免疫抑制剂(Immunosuppressive Agents);Kaplan-Meiers评估(Kaplan-Meier Estimate);肾移植(Kidney Transplantation);男(雄)性(Male);中年人(Middle Aged);回顾性研究(Retrospective Studies);危险因素(Risk Factors);西罗莫司(Sirolimus);TOR丝氨酸-苏氨酸激酶(TOR Serine-Threonine Kinases);时间因素(Time Factors);组织供者(Tissue Donors)

DOI 10.1371/journal.pone.0234396

PMID 32756556

发布时间 2021-12-04

检索历史清除

Early conversion to a CNI-free immunosuppression with SRL after renal transplantation-Long-term follow-up of a multicenter trial.

PloS one

相似文献

同项目论文

PloS one

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Early conversion to a CNI-free immunosuppression with SRL after renal transplantation-Long-term follow-up of a multicenter trial.

PloS one

相似文献

同项目论文

PloS one

相关期刊

检索历史清除